nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—urine—urinary bladder cancer	0.0277	0.216	CbGeAlD
Baclofen—GABBR1—prostate gland—urinary bladder cancer	0.0251	0.196	CbGeAlD
Baclofen—GABBR1—seminal vesicle—urinary bladder cancer	0.0213	0.166	CbGeAlD
Baclofen—GABBR1—urethra—urinary bladder cancer	0.0168	0.131	CbGeAlD
Baclofen—GABBR1—vagina—urinary bladder cancer	0.0124	0.0969	CbGeAlD
Baclofen—SLC22A8—prostate gland—urinary bladder cancer	0.00993	0.0776	CbGeAlD
Baclofen—Ibuprofen—UGT2B7—urinary bladder cancer	0.00895	0.402	CrCbGaD
Baclofen—GABBR1—lymph node—urinary bladder cancer	0.00803	0.0627	CbGeAlD
Baclofen—SLC22A8—renal system—urinary bladder cancer	0.00677	0.0529	CbGeAlD
Baclofen—Ibuprofen—CXCL8—urinary bladder cancer	0.00505	0.227	CrCbGaD
Baclofen—Ibuprofen—PPARG—urinary bladder cancer	0.00349	0.157	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—urinary bladder cancer	0.0033	0.148	CrCbGaD
Baclofen—Ibuprofen—PTGS2—urinary bladder cancer	0.00147	0.0662	CrCbGaD
Baclofen—Haematuria—Epirubicin—urinary bladder cancer	0.000536	0.00063	CcSEcCtD
Baclofen—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000532	0.000626	CcSEcCtD
Baclofen—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000531	0.000625	CcSEcCtD
Baclofen—Weight increased—Doxorubicin—urinary bladder cancer	0.000531	0.000624	CcSEcCtD
Baclofen—Pruritus—Gemcitabine—urinary bladder cancer	0.00053	0.000623	CcSEcCtD
Baclofen—Nausea—Thiotepa—urinary bladder cancer	0.000529	0.000622	CcSEcCtD
Baclofen—Urethral disorder—Methotrexate—urinary bladder cancer	0.000528	0.000622	CcSEcCtD
Baclofen—Weight decreased—Doxorubicin—urinary bladder cancer	0.000527	0.000621	CcSEcCtD
Baclofen—Feeling abnormal—Etoposide—urinary bladder cancer	0.000527	0.00062	CcSEcCtD
Baclofen—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000526	0.000619	CcSEcCtD
Baclofen—Pneumonia—Doxorubicin—urinary bladder cancer	0.000523	0.000615	CcSEcCtD
Baclofen—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000523	0.000615	CcSEcCtD
Baclofen—Pruritus—Fluorouracil—urinary bladder cancer	0.000521	0.000613	CcSEcCtD
Baclofen—Drowsiness—Doxorubicin—urinary bladder cancer	0.00052	0.000612	CcSEcCtD
Baclofen—Visual impairment—Methotrexate—urinary bladder cancer	0.000519	0.000611	CcSEcCtD
Baclofen—Bradycardia—Epirubicin—urinary bladder cancer	0.000513	0.000604	CcSEcCtD
Baclofen—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000512	0.000603	CcSEcCtD
Baclofen—Renal failure—Doxorubicin—urinary bladder cancer	0.000511	0.000601	CcSEcCtD
Baclofen—Urticaria—Etoposide—urinary bladder cancer	0.000508	0.000598	CcSEcCtD
Baclofen—Rhinitis—Epirubicin—urinary bladder cancer	0.000506	0.000595	CcSEcCtD
Baclofen—Abdominal pain—Etoposide—urinary bladder cancer	0.000505	0.000595	CcSEcCtD
Baclofen—Body temperature increased—Etoposide—urinary bladder cancer	0.000505	0.000595	CcSEcCtD
Baclofen—Eye disorder—Methotrexate—urinary bladder cancer	0.000504	0.000593	CcSEcCtD
Baclofen—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000504	0.000593	CcSEcCtD
Baclofen—Tinnitus—Methotrexate—urinary bladder cancer	0.000502	0.000591	CcSEcCtD
Baclofen—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000502	0.000591	CcSEcCtD
Baclofen—Asthenia—Cisplatin—urinary bladder cancer	0.000501	0.000589	CcSEcCtD
Baclofen—Cardiac disorder—Methotrexate—urinary bladder cancer	0.0005	0.000589	CcSEcCtD
Baclofen—Sweating—Doxorubicin—urinary bladder cancer	0.000498	0.000586	CcSEcCtD
Baclofen—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000498	0.000586	CcSEcCtD
Baclofen—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000497	0.000585	CcSEcCtD
Baclofen—Haematuria—Doxorubicin—urinary bladder cancer	0.000496	0.000583	CcSEcCtD
Baclofen—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000496	0.000583	CcSEcCtD
Baclofen—Urethral disorder—Epirubicin—urinary bladder cancer	0.000494	0.000582	CcSEcCtD
Baclofen—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000492	0.000579	CcSEcCtD
Baclofen—Angiopathy—Methotrexate—urinary bladder cancer	0.000489	0.000575	CcSEcCtD
Baclofen—Dizziness—Fluorouracil—urinary bladder cancer	0.000487	0.000573	CcSEcCtD
Baclofen—Visual impairment—Epirubicin—urinary bladder cancer	0.000486	0.000572	CcSEcCtD
Baclofen—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000486	0.000572	CcSEcCtD
Baclofen—Chills—Methotrexate—urinary bladder cancer	0.000484	0.000569	CcSEcCtD
Baclofen—Diarrhoea—Cisplatin—urinary bladder cancer	0.000477	0.000562	CcSEcCtD
Baclofen—Alopecia—Methotrexate—urinary bladder cancer	0.000476	0.00056	CcSEcCtD
Baclofen—Vomiting—Gemcitabine—urinary bladder cancer	0.000476	0.00056	CcSEcCtD
Baclofen—Bradycardia—Doxorubicin—urinary bladder cancer	0.000475	0.000559	CcSEcCtD
Baclofen—Mental disorder—Methotrexate—urinary bladder cancer	0.000472	0.000556	CcSEcCtD
Baclofen—Rash—Gemcitabine—urinary bladder cancer	0.000472	0.000555	CcSEcCtD
Baclofen—Dermatitis—Gemcitabine—urinary bladder cancer	0.000472	0.000555	CcSEcCtD
Baclofen—Eye disorder—Epirubicin—urinary bladder cancer	0.000471	0.000555	CcSEcCtD
Baclofen—Tinnitus—Epirubicin—urinary bladder cancer	0.00047	0.000553	CcSEcCtD
Baclofen—Malnutrition—Methotrexate—urinary bladder cancer	0.000469	0.000552	CcSEcCtD
Baclofen—Headache—Gemcitabine—urinary bladder cancer	0.000469	0.000552	CcSEcCtD
Baclofen—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000468	0.000551	CcSEcCtD
Baclofen—Flushing—Epirubicin—urinary bladder cancer	0.000468	0.000551	CcSEcCtD
Baclofen—Vomiting—Fluorouracil—urinary bladder cancer	0.000468	0.000551	CcSEcCtD
Baclofen—Rhinitis—Doxorubicin—urinary bladder cancer	0.000468	0.000551	CcSEcCtD
Baclofen—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000464	0.000546	CcSEcCtD
Baclofen—Rash—Fluorouracil—urinary bladder cancer	0.000464	0.000546	CcSEcCtD
Baclofen—Dermatitis—Fluorouracil—urinary bladder cancer	0.000464	0.000546	CcSEcCtD
Baclofen—Headache—Fluorouracil—urinary bladder cancer	0.000461	0.000543	CcSEcCtD
Baclofen—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000461	0.000542	CcSEcCtD
Baclofen—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00046	0.000541	CcSEcCtD
Baclofen—Dysgeusia—Methotrexate—urinary bladder cancer	0.000459	0.000541	CcSEcCtD
Baclofen—Asthenia—Etoposide—urinary bladder cancer	0.000459	0.00054	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000459	0.00054	CcSEcCtD
Baclofen—Angiopathy—Epirubicin—urinary bladder cancer	0.000458	0.000539	CcSEcCtD
Baclofen—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000457	0.000538	CcSEcCtD
Baclofen—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000455	0.000535	CcSEcCtD
Baclofen—Back pain—Methotrexate—urinary bladder cancer	0.000454	0.000534	CcSEcCtD
Baclofen—Chills—Epirubicin—urinary bladder cancer	0.000453	0.000533	CcSEcCtD
Baclofen—Pruritus—Etoposide—urinary bladder cancer	0.000452	0.000532	CcSEcCtD
Baclofen—Arrhythmia—Epirubicin—urinary bladder cancer	0.000451	0.00053	CcSEcCtD
Baclofen—Visual impairment—Doxorubicin—urinary bladder cancer	0.00045	0.000529	CcSEcCtD
Baclofen—Alopecia—Epirubicin—urinary bladder cancer	0.000446	0.000524	CcSEcCtD
Baclofen—Nausea—Gemcitabine—urinary bladder cancer	0.000445	0.000523	CcSEcCtD
Baclofen—Vomiting—Cisplatin—urinary bladder cancer	0.000444	0.000522	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—urinary bladder cancer	0.000442	0.00052	CcSEcCtD
Baclofen—Mental disorder—Epirubicin—urinary bladder cancer	0.000442	0.00052	CcSEcCtD
Baclofen—Rash—Cisplatin—urinary bladder cancer	0.00044	0.000518	CcSEcCtD
Baclofen—Dermatitis—Cisplatin—urinary bladder cancer	0.00044	0.000517	CcSEcCtD
Baclofen—Malnutrition—Epirubicin—urinary bladder cancer	0.000439	0.000517	CcSEcCtD
Baclofen—Diarrhoea—Etoposide—urinary bladder cancer	0.000437	0.000515	CcSEcCtD
Baclofen—Nausea—Fluorouracil—urinary bladder cancer	0.000437	0.000515	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—urinary bladder cancer	0.000436	0.000513	CcSEcCtD
Baclofen—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000435	0.000512	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—urinary bladder cancer	0.000435	0.000512	CcSEcCtD
Baclofen—Anaemia—Methotrexate—urinary bladder cancer	0.000434	0.00051	CcSEcCtD
Baclofen—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000433	0.00051	CcSEcCtD
Baclofen—Flushing—Doxorubicin—urinary bladder cancer	0.000433	0.00051	CcSEcCtD
Baclofen—Flatulence—Epirubicin—urinary bladder cancer	0.000433	0.000509	CcSEcCtD
Baclofen—Dysgeusia—Epirubicin—urinary bladder cancer	0.00043	0.000506	CcSEcCtD
Baclofen—Back pain—Epirubicin—urinary bladder cancer	0.000425	0.0005	CcSEcCtD
Baclofen—Angiopathy—Doxorubicin—urinary bladder cancer	0.000423	0.000498	CcSEcCtD
Baclofen—Malaise—Methotrexate—urinary bladder cancer	0.000423	0.000498	CcSEcCtD
Baclofen—Dizziness—Etoposide—urinary bladder cancer	0.000423	0.000497	CcSEcCtD
Baclofen—Vertigo—Methotrexate—urinary bladder cancer	0.000421	0.000496	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000421	0.000495	CcSEcCtD
Baclofen—Chills—Doxorubicin—urinary bladder cancer	0.000419	0.000493	CcSEcCtD
Baclofen—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000417	0.000491	CcSEcCtD
Baclofen—Nausea—Cisplatin—urinary bladder cancer	0.000414	0.000488	CcSEcCtD
Baclofen—Vision blurred—Epirubicin—urinary bladder cancer	0.000414	0.000487	CcSEcCtD
Baclofen—Alopecia—Doxorubicin—urinary bladder cancer	0.000412	0.000485	CcSEcCtD
Baclofen—Mental disorder—Doxorubicin—urinary bladder cancer	0.000409	0.000481	CcSEcCtD
Baclofen—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000407	0.000479	CcSEcCtD
Baclofen—Convulsion—Methotrexate—urinary bladder cancer	0.000406	0.000478	CcSEcCtD
Baclofen—Vomiting—Etoposide—urinary bladder cancer	0.000406	0.000478	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—urinary bladder cancer	0.000406	0.000478	CcSEcCtD
Baclofen—Anaemia—Epirubicin—urinary bladder cancer	0.000406	0.000478	CcSEcCtD
Baclofen—Agitation—Epirubicin—urinary bladder cancer	0.000403	0.000475	CcSEcCtD
Baclofen—Rash—Etoposide—urinary bladder cancer	0.000403	0.000474	CcSEcCtD
Baclofen—Dermatitis—Etoposide—urinary bladder cancer	0.000403	0.000474	CcSEcCtD
Baclofen—Headache—Etoposide—urinary bladder cancer	0.0004	0.000471	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—urinary bladder cancer	0.0004	0.000471	CcSEcCtD
Baclofen—Chest pain—Methotrexate—urinary bladder cancer	0.000399	0.00047	CcSEcCtD
Baclofen—Myalgia—Methotrexate—urinary bladder cancer	0.000399	0.00047	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000398	0.000468	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000397	0.000467	CcSEcCtD
Baclofen—Malaise—Epirubicin—urinary bladder cancer	0.000396	0.000466	CcSEcCtD
Baclofen—Discomfort—Methotrexate—urinary bladder cancer	0.000395	0.000464	CcSEcCtD
Baclofen—Vertigo—Epirubicin—urinary bladder cancer	0.000394	0.000464	CcSEcCtD
Baclofen—Syncope—Epirubicin—urinary bladder cancer	0.000394	0.000463	CcSEcCtD
Baclofen—Back pain—Doxorubicin—urinary bladder cancer	0.000393	0.000462	CcSEcCtD
Baclofen—Palpitations—Epirubicin—urinary bladder cancer	0.000388	0.000457	CcSEcCtD
Baclofen—Confusional state—Methotrexate—urinary bladder cancer	0.000386	0.000454	CcSEcCtD
Baclofen—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000386	0.000454	CcSEcCtD
Baclofen—Vision blurred—Doxorubicin—urinary bladder cancer	0.000383	0.000451	CcSEcCtD
Baclofen—Convulsion—Epirubicin—urinary bladder cancer	0.00038	0.000448	CcSEcCtD
Baclofen—Infection—Methotrexate—urinary bladder cancer	0.00038	0.000448	CcSEcCtD
Baclofen—Nausea—Etoposide—urinary bladder cancer	0.00038	0.000447	CcSEcCtD
Baclofen—Hypertension—Epirubicin—urinary bladder cancer	0.000379	0.000446	CcSEcCtD
Baclofen—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000377	0.000444	CcSEcCtD
Baclofen—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000375	0.000442	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—urinary bladder cancer	0.000375	0.000442	CcSEcCtD
Baclofen—Myalgia—Epirubicin—urinary bladder cancer	0.000374	0.00044	CcSEcCtD
Baclofen—Chest pain—Epirubicin—urinary bladder cancer	0.000374	0.00044	CcSEcCtD
Baclofen—Agitation—Doxorubicin—urinary bladder cancer	0.000373	0.000439	CcSEcCtD
Baclofen—Anxiety—Epirubicin—urinary bladder cancer	0.000372	0.000438	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—urinary bladder cancer	0.000372	0.000438	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000371	0.000437	CcSEcCtD
Baclofen—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00037	0.000436	CcSEcCtD
Baclofen—Discomfort—Epirubicin—urinary bladder cancer	0.000369	0.000435	CcSEcCtD
Baclofen—Malaise—Doxorubicin—urinary bladder cancer	0.000366	0.000431	CcSEcCtD
Baclofen—Dry mouth—Epirubicin—urinary bladder cancer	0.000366	0.00043	CcSEcCtD
Baclofen—Vertigo—Doxorubicin—urinary bladder cancer	0.000365	0.00043	CcSEcCtD
Baclofen—Anorexia—Methotrexate—urinary bladder cancer	0.000365	0.00043	CcSEcCtD
Baclofen—Syncope—Doxorubicin—urinary bladder cancer	0.000364	0.000429	CcSEcCtD
Baclofen—Confusional state—Epirubicin—urinary bladder cancer	0.000361	0.000425	CcSEcCtD
Baclofen—Palpitations—Doxorubicin—urinary bladder cancer	0.000359	0.000422	CcSEcCtD
Baclofen—Oedema—Epirubicin—urinary bladder cancer	0.000358	0.000422	CcSEcCtD
Baclofen—Hypotension—Methotrexate—urinary bladder cancer	0.000358	0.000421	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000357	0.00042	CcSEcCtD
Baclofen—Infection—Epirubicin—urinary bladder cancer	0.000356	0.000419	CcSEcCtD
Baclofen—Shock—Epirubicin—urinary bladder cancer	0.000353	0.000415	CcSEcCtD
Baclofen—Convulsion—Doxorubicin—urinary bladder cancer	0.000352	0.000414	CcSEcCtD
Baclofen—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000351	0.000414	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—urinary bladder cancer	0.000351	0.000413	CcSEcCtD
Baclofen—Tachycardia—Epirubicin—urinary bladder cancer	0.00035	0.000412	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000349	0.000411	CcSEcCtD
Baclofen—Skin disorder—Epirubicin—urinary bladder cancer	0.000348	0.00041	CcSEcCtD
Baclofen—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000346	0.000408	CcSEcCtD
Baclofen—Insomnia—Methotrexate—urinary bladder cancer	0.000346	0.000408	CcSEcCtD
Baclofen—Chest pain—Doxorubicin—urinary bladder cancer	0.000346	0.000407	CcSEcCtD
Baclofen—Myalgia—Doxorubicin—urinary bladder cancer	0.000346	0.000407	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—urinary bladder cancer	0.000345	0.000406	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—urinary bladder cancer	0.000344	0.000405	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000343	0.000404	CcSEcCtD
Baclofen—Discomfort—Doxorubicin—urinary bladder cancer	0.000342	0.000402	CcSEcCtD
Baclofen—Anorexia—Epirubicin—urinary bladder cancer	0.000342	0.000402	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—urinary bladder cancer	0.000341	0.000402	CcSEcCtD
Baclofen—Somnolence—Methotrexate—urinary bladder cancer	0.00034	0.000401	CcSEcCtD
Baclofen—Dry mouth—Doxorubicin—urinary bladder cancer	0.000338	0.000398	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—urinary bladder cancer	0.000337	0.000397	CcSEcCtD
Baclofen—Hypotension—Epirubicin—urinary bladder cancer	0.000335	0.000394	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—urinary bladder cancer	0.000334	0.000393	CcSEcCtD
Baclofen—Decreased appetite—Methotrexate—urinary bladder cancer	0.000333	0.000392	CcSEcCtD
Baclofen—Oedema—Doxorubicin—urinary bladder cancer	0.000332	0.00039	CcSEcCtD
Baclofen—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000331	0.000389	CcSEcCtD
Baclofen—Fatigue—Methotrexate—urinary bladder cancer	0.00033	0.000388	CcSEcCtD
Baclofen—Infection—Doxorubicin—urinary bladder cancer	0.000329	0.000388	CcSEcCtD
Baclofen—Pain—Methotrexate—urinary bladder cancer	0.000327	0.000385	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000326	0.000384	CcSEcCtD
Baclofen—Shock—Doxorubicin—urinary bladder cancer	0.000326	0.000384	CcSEcCtD
Baclofen—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000325	0.000383	CcSEcCtD
Baclofen—Insomnia—Epirubicin—urinary bladder cancer	0.000324	0.000381	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—urinary bladder cancer	0.000324	0.000381	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—urinary bladder cancer	0.000322	0.000379	CcSEcCtD
Baclofen—Paraesthesia—Epirubicin—urinary bladder cancer	0.000322	0.000379	CcSEcCtD
Baclofen—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000321	0.000377	CcSEcCtD
Baclofen—Dyspnoea—Epirubicin—urinary bladder cancer	0.000319	0.000376	CcSEcCtD
Baclofen—Somnolence—Epirubicin—urinary bladder cancer	0.000319	0.000375	CcSEcCtD
Baclofen—Anorexia—Doxorubicin—urinary bladder cancer	0.000316	0.000372	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000316	0.000371	CcSEcCtD
Baclofen—Dyspepsia—Epirubicin—urinary bladder cancer	0.000315	0.000371	CcSEcCtD
Baclofen—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000313	0.000368	CcSEcCtD
Baclofen—Decreased appetite—Epirubicin—urinary bladder cancer	0.000311	0.000367	CcSEcCtD
Baclofen—Hypotension—Doxorubicin—urinary bladder cancer	0.00031	0.000365	CcSEcCtD
Baclofen—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000309	0.000364	CcSEcCtD
Baclofen—Fatigue—Epirubicin—urinary bladder cancer	0.000309	0.000364	CcSEcCtD
Baclofen—Pain—Epirubicin—urinary bladder cancer	0.000306	0.000361	CcSEcCtD
Baclofen—Constipation—Epirubicin—urinary bladder cancer	0.000306	0.000361	CcSEcCtD
Baclofen—Urticaria—Methotrexate—urinary bladder cancer	0.000304	0.000358	CcSEcCtD
Baclofen—Body temperature increased—Methotrexate—urinary bladder cancer	0.000303	0.000356	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—urinary bladder cancer	0.000303	0.000356	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000302	0.000355	CcSEcCtD
Baclofen—Insomnia—Doxorubicin—urinary bladder cancer	0.0003	0.000353	CcSEcCtD
Baclofen—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000298	0.00035	CcSEcCtD
Baclofen—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000296	0.000348	CcSEcCtD
Baclofen—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000295	0.000347	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—urinary bladder cancer	0.000295	0.000347	CcSEcCtD
Baclofen—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000293	0.000345	CcSEcCtD
Baclofen—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000292	0.000343	CcSEcCtD
Baclofen—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000288	0.000339	CcSEcCtD
Baclofen—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000286	0.000337	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—urinary bladder cancer	0.000286	0.000336	CcSEcCtD
Baclofen—Urticaria—Epirubicin—urinary bladder cancer	0.000285	0.000335	CcSEcCtD
Baclofen—Constipation—Doxorubicin—urinary bladder cancer	0.000284	0.000334	CcSEcCtD
Baclofen—Pain—Doxorubicin—urinary bladder cancer	0.000284	0.000334	CcSEcCtD
Baclofen—Body temperature increased—Epirubicin—urinary bladder cancer	0.000283	0.000333	CcSEcCtD
Baclofen—Abdominal pain—Epirubicin—urinary bladder cancer	0.000283	0.000333	CcSEcCtD
Baclofen—Asthenia—Methotrexate—urinary bladder cancer	0.000275	0.000323	CcSEcCtD
Baclofen—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000273	0.000322	CcSEcCtD
Baclofen—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000271	0.000319	CcSEcCtD
Baclofen—Pruritus—Methotrexate—urinary bladder cancer	0.000271	0.000319	CcSEcCtD
Baclofen—Urticaria—Doxorubicin—urinary bladder cancer	0.000263	0.00031	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000262	0.000308	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000262	0.000308	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—urinary bladder cancer	0.000262	0.000308	CcSEcCtD
Baclofen—Asthenia—Epirubicin—urinary bladder cancer	0.000257	0.000303	CcSEcCtD
Baclofen—Pruritus—Epirubicin—urinary bladder cancer	0.000254	0.000298	CcSEcCtD
Baclofen—Dizziness—Methotrexate—urinary bladder cancer	0.000253	0.000298	CcSEcCtD
Baclofen—Diarrhoea—Epirubicin—urinary bladder cancer	0.000245	0.000289	CcSEcCtD
Baclofen—Vomiting—Methotrexate—urinary bladder cancer	0.000243	0.000286	CcSEcCtD
Baclofen—Rash—Methotrexate—urinary bladder cancer	0.000241	0.000284	CcSEcCtD
Baclofen—Dermatitis—Methotrexate—urinary bladder cancer	0.000241	0.000284	CcSEcCtD
Baclofen—Headache—Methotrexate—urinary bladder cancer	0.00024	0.000282	CcSEcCtD
Baclofen—Asthenia—Doxorubicin—urinary bladder cancer	0.000238	0.00028	CcSEcCtD
Baclofen—Dizziness—Epirubicin—urinary bladder cancer	0.000237	0.000279	CcSEcCtD
Baclofen—Pruritus—Doxorubicin—urinary bladder cancer	0.000235	0.000276	CcSEcCtD
Baclofen—Vomiting—Epirubicin—urinary bladder cancer	0.000228	0.000268	CcSEcCtD
Baclofen—Nausea—Methotrexate—urinary bladder cancer	0.000227	0.000268	CcSEcCtD
Baclofen—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000227	0.000267	CcSEcCtD
Baclofen—Rash—Epirubicin—urinary bladder cancer	0.000226	0.000266	CcSEcCtD
Baclofen—Dermatitis—Epirubicin—urinary bladder cancer	0.000226	0.000266	CcSEcCtD
Baclofen—Headache—Epirubicin—urinary bladder cancer	0.000224	0.000264	CcSEcCtD
Baclofen—Dizziness—Doxorubicin—urinary bladder cancer	0.000219	0.000258	CcSEcCtD
Baclofen—Nausea—Epirubicin—urinary bladder cancer	0.000213	0.00025	CcSEcCtD
Baclofen—Vomiting—Doxorubicin—urinary bladder cancer	0.000211	0.000248	CcSEcCtD
Baclofen—Rash—Doxorubicin—urinary bladder cancer	0.000209	0.000246	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—urinary bladder cancer	0.000209	0.000246	CcSEcCtD
Baclofen—Headache—Doxorubicin—urinary bladder cancer	0.000208	0.000244	CcSEcCtD
Baclofen—Nausea—Doxorubicin—urinary bladder cancer	0.000197	0.000232	CcSEcCtD
